Clinical Trials
11 trialsNCT03692325 2024-10-01
Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00099021 2022-02-11
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 2 Completed
NCT00299195 2020-11-19
A Randomized Study of Sulindac in Oral Premalignant Lesions
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00453336 2017-02-08
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract
University of Miami
Phase 2 Completed
NCT00330382 2014-12-19
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 2 Completed
NCT01238185 2013-08-12
Aspirin Mouthwash in Treating Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 1 Completed
NCT00101335 2013-07-11
Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Fox Chase Cancer Center
Phase 2 Completed
NCT00369174 2013-02-13
Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 2 Completed
NCT00155337 2012-12-21
Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia
National Taiwan University Hospital
Phase 4 Completed
NCT00002026 2005-06-24
Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)
NIH AIDS Clinical Trials Information Service
Phase NA Completed
NCT00002043 2005-06-24
Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)
NIH AIDS Clinical Trials Information Service
Phase NA Completed